Advances in glucocorticoid-mediated stroke-associated immunosuppression

Journal of Translational Neuroscience ›› 2023, Vol. 8 ›› Issue (3) : 1 -9.

PDF (9737KB)
Journal of Translational Neuroscience ›› 2023, Vol. 8 ›› Issue (3) : 1 -9. DOI: 10.3868/j.issn.2096-0689.2023.03.001
Review

Advances in glucocorticoid-mediated stroke-associated immunosuppression

Author information +
History +
PDF (9737KB)

Abstract

Acute ischemic stroke is often accompanied by complications such as infection. After acute ischemic stroke, immunosuppression can occur as a mechanism to prevent an excessive inflammatory response. Glucocorticoid, an important product of the hypothalamic-pituitary-adrenal axis, plays a crucial role in inducing immunosuppression in the early stage of acute cerebral infarction. Glucocorticoid not only affects the secretion of inflammatory cytokines but also influences the function of immune cells, ultimately leading to an increased risk of infection.

Keywords

acute ischemic stroke / stroke-associated immunosuppression / hypothalamic-pituitary-adrenal axis / glucocorticoid

Cite this article

Download citation ▾
null. Advances in glucocorticoid-mediated stroke-associated immunosuppression. Journal of Translational Neuroscience, 2023, 8(3): 1-9 DOI:10.3868/j.issn.2096-0689.2023.03.001

登录浏览全文

4963

注册一个新账户 忘记密码

References

AI Summary AI Mindmap
PDF (9737KB)

393

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/